The FY26 Vision Research Program Translational Research Award supports projects that transform promising discoveries into new drugs, devices, or clinical practice guidelines ready for definitive clinical trial testing. Funding covers preclinical studies, clinical research, or pilot clinical trials but excludes full-scale trials. Research must align with FY26 VRP Focus Areas and include regulatory expertise if developing drugs or devices. The award allows for dual PIs and emphasizes impact on military health.
Open to any type of entity, with no specific restrictions noted beyond additional clarifications in eligibility text. Research teams developing drugs or devices must include regulatory approval expertise.
